Triple-negative breast cancer (TNBC) is defined by the absence or extremely low expression of breast cancer-specific antigens, such as human epidermal growth factor receptor-2 (HER-2), estrogen receptor (ER), and progesterone receptor (PR) [2,3]. Here, PGR is linked to triple-negative breast carcinoma.